Merrimack Pharmaceuticals Aktie
WKN DE: A1JHBG / ISIN: US5903281005
10.11.2014 23:22:27
|
Merrimack Posts Q3 Loss/shr Of $0.27 - Quick Facts
(RTTNews) - Merrimack Pharmaceuticals, Inc. (MACK) reported a third-quarter net loss of $28.0 million or $0.27 per share, compared to a loss of $39.6 million or $0.39 per share, prior year.
On average, six analysts polled by Thomson Reuters expected the company to report a loss per share of $0.12 for the quarter. Analysts' estimates typically exclude special items.
Collaboration revenue increased to $28.0 million from $6.9 million last year. Analysts expected revenue of $21.79 million for the quarter.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Merrimack Pharmaceuticals Incmehr Nachrichten
Keine Nachrichten verfügbar. |